DrugPatentWatch Database Preview
Innogenix Company Profile
What is the competitive landscape for INNOGENIX, and what generic and branded alternatives to INNOGENIX drugs are available?
INNOGENIX has four approved drugs.
Summary for Innogenix
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Innogenix
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innogenix | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 075215-002 | Jul 29, 1999 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Innogenix | PILOCARPINE HYDROCHLORIDE | pilocarpine hydrochloride | TABLET;ORAL | 076963-001 | Dec 22, 2004 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Innogenix | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 075215-001 | Jul 29, 1999 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Innogenix | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 075215-003 | Jul 29, 1999 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Innogenix | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 078953-001 | Apr 15, 2010 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
